|
Summary:
the customer (aviles, spain) reported a potential false positive giardia lamblia (g.Lamblia) result on the biofire® filmarray® gastrointestinal (gi) panel after testing a patient stool sample.The customer reported that due to the gi panel result, the patient was indirectly impacted, specifically by inappropriate treatment, which might lead to serious injury if it were to recur.No patient harm was reported.Biofire has requested further information from the customer and is currently investigating this event.No remedial action, corrective action, preventive action, or field safety corrective action (fsca) has been deemed necessary at this time.
|